Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 30;8(6):1741-1755.
doi: 10.1021/acsptsci.5c00161. eCollection 2025 Jun 13.

Discovery of a Novel, Potent, and Selective 5‑Hydroxytryptamine 2B Receptor Antagonist that Induces Mitochondrial Biogenesis in the Kidney

Affiliations

Discovery of a Novel, Potent, and Selective 5‑Hydroxytryptamine 2B Receptor Antagonist that Induces Mitochondrial Biogenesis in the Kidney

Paul Victor Santiago Raj et al. ACS Pharmacol Transl Sci. .

Abstract

Serotonin, or 5-hydroxytryptamine (5-HT), is a multifaceted neurotransmitter that plays a vital role in the central nervous system (CNS). Beyond the CNS, 5-HT is intricately involved in modulating hemostasis, immune response, blood pressure, and metabolism in tissues such as skeletal muscle, heart, and kidney. Accumulating evidence highlights the interplay between 5-HT receptors and mitochondrial bioenergetics. Here, we report the discovery of a novel, potent, and selective 5-hydroxytryptamine 2B receptor (5-HT2BR) antagonist, MARY1, which induces mitochondrial biogenesis (MB) in the kidney. MARY1 is a small molecule belonging to the pyridinylpiperazine class that exhibits selectivity and moderate affinity (K i = 764 nM) for the human 5-HT2BR, as well as efficacy (IC50 = 380 nM; E max = 90%) in cellular-based binding and functional assays. Treatment with MARY1 (1 nM) increases mitochondrial respiratory capacity, mitochondrial protein levels, and mitochondrial number in renal proximal tubule cells (RPTCs). Mechanistically, the MB effects of MARY1 in RPTCs are mediated through 5-HT2BR and the activation of dual cell signaling pathways: PI3K/AKT and RAS/MEK/ERK. Moreover, MARY1 administration in mice and rats induces renal cortical MB, and increases levels of mitochondrial and fatty acid oxidation proteins. These findings identify MARY1 as a selective and potent 5-HT2BR antagonist that induces MB and enhances mitochondrial function in the kidney, offering a potential therapeutic strategy for metabolic and mitochondrial dysfunction-associated renal disorders.

Keywords: 5-HT2B receptor antagonist; mitochondrial biogenesis; mitochondrial dysfunction; piperazine.

PubMed Disclaimer

Similar articles

  • MARY1 Restores Mitochondrial Homeostasis and Accelerates Renal Recovery Following Acute Kidney Injury.
    Santiago Raj PV, Janda J, Scholpa NE, Hurtado KA, Schnellmann RG. Santiago Raj PV, et al. Am J Physiol Renal Physiol. 2025 Aug 26. doi: 10.1152/ajprenal.00232.2025. Online ahead of print. Am J Physiol Renal Physiol. 2025. PMID: 40857162
  • Management of urinary stones by experts in stone disease (ESD 2025).
    Papatsoris A, Geavlete B, Radavoi GD, Alameedee M, Almusafer M, Ather MH, Budia A, Cumpanas AA, Kiremi MC, Dellis A, Elhowairis M, Galán-Llopis JA, Geavlete P, Guimerà Garcia J, Isern B, Jinga V, Lopez JM, Mainez JA, Mitsogiannis I, Mora Christian J, Moussa M, Multescu R, Oguz Acar Y, Petkova K, Piñero A, Popov E, Ramos Cebrian M, Rascu S, Siener R, Sountoulides P, Stamatelou K, Syed J, Trinchieri A. Papatsoris A, et al. Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
  • Short-Term Memory Impairment.
    Cascella M, Al Khalili Y. Cascella M, et al. 2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31424720 Free Books & Documents.
  • Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.
    Weibel S, Rücker G, Eberhart LH, Pace NL, Hartl HM, Jordan OL, Mayer D, Riemer M, Schaefer MS, Raj D, Backhaus I, Helf A, Schlesinger T, Kienbaum P, Kranke P. Weibel S, et al. Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2. Cochrane Database Syst Rev. 2020. PMID: 33075160 Free PMC article.
  • The Black Book of Psychotropic Dosing and Monitoring.
    DeBattista C, Schatzberg AF. DeBattista C, et al. Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.

References

    1. Young S. N.. How to increase serotonin in the human brain without drugs. J. Psychiatry Neurosci. 2007;32:394–399. - PMC - PubMed
    1. Hurtado K., Scholpa N. E., Schnellmann J. G., Schnellmann R. G.. Serotonin regulation of mitochondria in kidney diseases. Pharmacol. Res. 2024;203:107154. doi: 10.1016/j.phrs.2024.107154. - DOI - PMC - PubMed
    1. Eison A. S., Mullins U. L.. Regulation of central 5-HT2A receptors: A review of in vivo studies. Behav. Brain Res. 1995;73:177–181. doi: 10.1016/0166-4328(96)00092-7. - DOI - PubMed
    1. Wenglen C., Demirel I., Eremo A. G., Grenegard M., Paramel G. V.. Targeting serotonin receptor 2B inhibits TGFbeta induced differentiation of human vascular smooth muscle cells. Eur. J. Pharmacol. 2023;944:175570. doi: 10.1016/j.ejphar.2023.175570. - DOI - PubMed
    1. Flanagan T. W., Sebastian M. N., Battaglia D. M., Foster T. P., Maillet E. L., Nichols C. D.. Activation of 5-HT(2) Receptors Reduces Inflammation in Vascular Tissue and Cholesterol Levels in High-Fat Diet-Fed Apolipoprotein E Knockout Mice. Sci. Rep. 2019;9:13444. doi: 10.1038/s41598-019-49987-0. - DOI - PMC - PubMed

LinkOut - more resources